Hearing Loss Disease Portal


 
Switch to table view
Most Common: Hearing Loss (D034381), Deafness (D003638), Sensorineural HL (D006319), Waardenburg Syndrome, Usher Syndromes
Disease Browser
Parent Node:
expand
Blood Coagulation Disorders (D001778)
Parent Node:
expand
Hemorrhagic Disorders (D006474)
Parent Node:
expand
Thrombocytosis (D013922)
..Starting node
..expand
Thrombocythemia, Essential (D013920)

       Child Nodes:



 Sister Nodes: 
..expandThrombocythemia, Essential (D013920)
..expandTHROMBOCYTHEMIA, X-LINKED (OMIM:300331)
..expandThrombocytosis, Benign Familial Microcytic (C566596)
..expandThrombocytosis, Familial X-Linked (C564532)
   

Human Disease MESH is developed by UMLS.
Further data from MedGen, OMIM, CTD
Term ID:10987
Name:Thrombocythemia, Essential
Definition:A clinical syndrome characterized by repeated spontaneous hemorrhages and a remarkable increase in the number of circulating platelets.
Alternative IDs:OMIM:187950
ParentIDs:MESH:D001778|MESH:D006474|MESH:D013922
TreeNumbers:C15.378.100.832 |C15.378.140.860.800 |C15.378.190.636.860.800 |C15.378.463.825
Synonyms:Autosomal Dominant Thrombocytoses |Autosomal Dominant Thrombocytosis |Dominant Thrombocytoses, Autosomal |Dominant Thrombocytosis, Autosomal |Essential Thrombocythemia |Essential Thrombocythemias |Hemorrhagic Thrombocythemia |Hemorrhagic Thrombocythemias |Idiopa
Slim Mappings:Blood disease
Reference: MedGen: D013920
MeSH: D013920
OMIM: 187950;

Genes: CALR; SH2B3; THPO;
Phenotypes
1 HP:0000006Autosomal dominant inheritance
2 HP:0000924Abnormality of the skeletal system
3 HP:0001063Acrocyanosis
4 HP:0000822Hypertension
5 HP:0003540Impaired platelet aggregation
6 HP:0005547Myeloproliferative disorder
7 HP:0001428Somatic mutation
8 HP:0001744Splenomegaly
9 HP:0001894Thrombocytosis
Disease Causing ClinVar Variants
Variation_NameGeneIDGeneSymbolClinicalSignificancedbSNPRCVaccessionTestedInGTRPhenotypeIDsChromosomeStartStopHGVS_cHGVS_pHGVS_gOtherIDsDisease_ClinVarDisease_hgmd
NC_000014.9:g.95696766_96390792dup694027-1-Likely pathogenic-1RCV000190403; RCV000190405; RCV000190404; RCV000190406; NMedGen:C0001815,OMIM:254450; MedGen:C0023467,OMIM:601626, Orphanet:ORPHA519,SNOMED CT:17788007; MedGen:C0040028,OMIM:187950,ORPHA:3318149616310396857129---C0023467 601626 Acute myeloid leukemia; C0040028 187950 Essential thrombocythemia; C0001815 254450 Myelofibrosis
NM_004343.3(CALR):c.1092_1143del52 (p.Leu367Thrfs)811CALRPathogenic-1RCV000083257; RCV000083256; NMedGen:C0001815,OMIM:254450; MedGen:C0040028,OMIM:187950,ORPHA:3318191305456513054616NM_004343.3:c.1092_1143del52NP_004334.1:p.Leu367ThrfsOMIM Allelic Variant:109091.0001,dbVar:nssv3761626,dbVar:nsv1067850C0040028 187950 Essential thrombocythemia; C0001815 254450 Myelofibrosis
NM_005475.2(SH2B3):c.622G>C (p.Glu208Gln)10019SH2B3Pathogenic202080221RCV000023398; NMedGen:C0040028,OMIM:187950,ORPHA:331812111856571111856571NM_005475.2:c.622G>CNP_005466.1:p.Glu208GlnNC_000012.11:g.111856571G>C,NC_000012.11:g.111856571G>TOMIM Allelic Variant:605093.0002C0040028 187950 Essential thrombocythemia